Ingrid A. Mayer

Also affiliated with AstraZeneca (Japan)

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 26 papers. Top paper: “Hydroxychloroquine as Pre-exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized Trial”.

Hydroxychloroquine as Pre-exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized Trial

Clinical Infectious Diseases(2020)10.1093/cid/ciaa1571

N/A

4.6DataRank · unranked

128 citations

Ananta Bangdiwala, Melanie R. Nicol, Caleb P Skipper, Katelyn A Pastick, Margaret L. Axelrod +30 more

Capivasertib, an AKT Kinase Inhibitor, as Monotherapy or in Combination with Fulvestrant in Patients with AKT1 E17K-Mutant, ER-Positive Metastatic Breast Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3953

N/A

3.2DataRank · unranked

108 citations

Kenji Tamura, Mafalda Oliveira, Eva Ciruelos, Ingrid A. Mayer, Marie‐Paule Sablin +23 more

Evaluation of Alisertib Alone or Combined With Fulvestrant in Patients With Endocrine-Resistant Advanced Breast Cancer

JAMA Oncology(2023)10.1001/jamaoncol.2022.7949

N/A

1.4DataRank · unranked

52 citations

Vera J. Suman, Antonino B. D’Assoro, Jodi M. Carter, Karthik V. Giridhar, Brendan P. McMenomy +18 more

Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer

Cancer Research(2023)10.1158/0008-5472.can-23-1711

N/A

0.596DataRank · unranked

15 citations

Yingtian Xie, Shira Sherman, Zsuzsanna Nagy, Douglas Russo, Tara Akhshi +36 more

Impact of molecular subtype and race on HR+, HER2− breast cancer survival

Breast Cancer Research and Treatment(2021)10.1007/s10549-021-06342-0

N/A

0.470DataRank · unranked

22 citations

Diane N. Haddad, Ann Tezak, Anne Weidner, Xuefeng Wang, Brian S. Mautz +8 more

A randomized phase III double-blind placebo-controlled trial of first-line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105)

Breast Cancer Research and Treatment(2024)10.1007/s10549-024-07417-4

N/A

0.215DataRank · unranked

3 citations

Anne O’Neill, Ingrid A. Mayer, Carlos L. Arteaga, Ximing J. Yang, Lynne I. Wagner +17 more

Reply to T. Shimoi et al and Y. Shimanuki et al

Journal of Clinical Oncology(2021)10.1200/jco.21.01905

N/A

0.209DataRank · unranked

2 citations

Fengmin Zhao, Carlos L. Arteaga, W. Fraser Symmans, Ben Ho Park, Brian L. Burnette +20 more

Adjuvant platinum versus capecitabine for residual, invasive, triple‐negative breast cancer: Patient‐reported outcomes in ECOG‐ACRIN EA1131

Cancer(2024)10.1002/cncr.35187

N/A

0.208DataRank · unranked

3 citations

Fengmin Zhao, Ingrid A. Mayer, Amyé Tevaarwerk, Sofia F. Garcia, Carlos L. Arteaga +20 more

Neighborhood socioeconomic disadvantage, tobacco use, and cessation indicators among adults with cancer in the United States: Results from 10 ECOG-ACRIN trials.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.6514

N/A

0.189DataRank · unranked

2 citations

Ju‐Whei Lee, Ilana F. Gareen, Sheetal Kircher, B. Herman, Joanna M. Streck +14 more

Inhibition of the PI3K/mTOR Pathway in Breast Cancer to Enhance Response to Immune Checkpoint Inhibitors in Breast Cancer

International Journal of Molecular Sciences(2021)10.3390/ijms22105207

N/A

0DataRank · unranked

73 citations

Jinming Yang, Nabil Saleh, Sheau‐Chiann Chen, Gregory D. Ayers, Vandana G. Abramson +3 more

Human and Machine Intelligence Together Drive Drug Repurposing in Rare Diseases

Frontiers in Genetics(2021)10.3389/fgene.2021.707836

N/A

0DataRank · unranked

23 citations

Nicole M. Zaleski, Rebecca N Jerome, Robert R. Lavieri, Jana K. Shirey-Rice, April Barnado +9 more

Prospective Validation of a 21-Gene Expression Assay in Breast Cancer

Digital Commons@Becker (Washington University School of Medicine)(2020)10.17615/6e7v-pv95

N/A

0DataRank · unranked

1 citations

Tracy Lively, John A. Olson, Robert J. Gray, Virginia Kaklamani, Della Makower +26 more

A randomized phase III post-operative trial of platinum-based chemotherapy (P) versus capecitabine (C) in patients (pts) with residual triple-negative breast cancer (TNBC) following neoadjuvant chemotherapy (NAC): ECOG-ACRIN EA1131

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.605

N/A

0DataRank · unranked

7 citations

Fengmin Zhao, Carlos L. Arteaga, W. Fraser Symmans, Ben Ho Park, Brian L. Burnette +12 more

Correlative studies investigating effects of PI3K inhibition on peripheral leukocytes in metastatic breast cancer: potential implications for immunotherapy

Breast Cancer Research and Treatment(2020)10.1007/s10549-020-05846-5

N/A

0DataRank · unranked

6 citations

Caroline A. Nebhan, Jinming Yang, Lauren S. Starnes, Chi Yan, Anna E. Vilgelm +6 more

Peripheral Blood Monocyte Abundance Predicts Outcomes in Patients with Breast Cancer

Cancer Research Communications(2022)10.1158/2767-9764.crc-22-0023

N/A

0DataRank · unranked

12 citations

Yu Wang, Yaomin Xu, Xiaopeng Sun, Cosmin A. Bejan, Paula I. González-Ericsson +10 more

Reciprocal expression of Annexin A6 and RasGRF2 discriminates rapidly growing from invasive triple negative breast cancer subsets

PLoS ONE(2020)10.1371/journal.pone.0231711

N/A

0DataRank · unranked

17 citations

Sarrah E. Widatalla, Diva S. Whalen, Gladys N. Nangami, Adeniyi Abimbola, Stephen D. Williams +8 more

Changes in Peripheral and Local Tumor Immunity after Neoadjuvant Chemotherapy Reshape Clinical Outcomes in Patients with Breast Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3685

N/A

0DataRank · unranked

60 citations

Mellissa J. Nixon, Paula I. González-Ericsson, Riley E. Bergman, Mark A. Pilkinton, Wyatt J. McDonnell +21 more

Use of focused computerized cognitive training (Neuroflex) to improve symptoms in women with persistent chemotherapy-related cognitive impairment

Digital Health(2023)10.1177/20552076231192754

N/A

0DataRank · unranked

8 citations

Paul Newhouse, Alexander C. Conley, Sarah M. Szymkowicz, Xuewen Gong, Sarah Côté +4 more

Cigarette and Alternative Tobacco Product Use among Adult Cancer Survivors Enrolled in 9 ECOG-ACRIN Clinical Trials

Cancer Epidemiology Biomarkers & Prevention(2023)10.1158/1055-9965.epi-23-0420

N/A

0DataRank · unranked

7 citations

Ju‐Whei Lee, Angela Wangari Walter, Rachel Rosen, Ilana F. Gareen, Sheetal Mehta Kircher +17 more

Oral paclitaxel, carboplatin, and dostarlimab (OPE/Cb/D) without and with trastuzumab in early-stage, high-risk breast cancer: Results from the neoadjuvant I-SPY 2 TRIAL.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.17_suppl.lba520

N/A

0DataRank · unranked

2 citations

Kevin Kalinsky, Christina Yau, A. Jo Chien, Judy C. Boughey, Erica Stringer-Reasor +15 more

Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial

JNCI Journal of the National Cancer Institute(2020)10.1093/jnci/djaa148

N/A

0DataRank · unranked

115 citations

Robert J. Gray, Della Makower, Amir Faghih, Daniel F. Hayes, Charles E. Geyer +23 more

Cigarette Smoking and Symptom Burden: Baseline Results From Nine ECOG-ACRIN Cancer Clinical Trials

Journal of Pain and Symptom Management(2024)10.1016/j.jpainsymman.2024.12.021

N/A

0DataRank · unranked

2 citations

Ju‐Whei Lee, Ilana F. Gareen, Sheetal Mehta Kircher, Shaji Kumar, Ingrid A. Mayer +10 more

A randomized phase III double-blind placebo-controlled trial of first line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105)

Research Square(2024)10.21203/rs.3.rs-4295044/v1

N/A

0DataRank · unranked

0 citations

Anne O’Neill, Ingrid A. Mayer, Carlos L. Arteaga, Ximing J. Yang, Lynne I. Wagner +17 more

Predictive value of bother by side effects of treatment prior to protocol therapy for early treatment discontinuation in clinical trials.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e19132

N/A

0DataRank · unranked

3 citations

John Devin Peipert, Ju‐Whei Lee, Fangxin Hong, Edward H. Ip, Ilana F. Gareen +15 more

The effect of neighborhood socioeconomic disadvantage on smoking status, quit attempts, and receipt of cessation support among adults with cancer: Results from nine ECOG‐ACRIN Cancer Research Group trials

UNC Libraries(2025)10.17615/c1xc-d466

N/A

0DataRank · unranked

0 citations

Ju‐Whei Lee, Sheetal Mehta Kircher, Lynne I. Wagner, Frank S. Hodi, Jamie S. Ostroff +16 more

The association between race and intrinsic subtype on hormone receptor-positive breast cancer among young black women.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e12591

N/A

0DataRank · unranked

0 citations

Jaleesa Moore, Ann Tezak, Anne Weidner, Ingrid A. Mayer, Tuya Pal +1 more